Figure 5.
Mitochondria-targeted metformin enhances oxygen concentration in pancreatic cancer cells by inhibiting mitochondrial respiration and makes these cells more vulnerable to radiation. *, P < 0.05 compared with radiation alone. The left portion of the figure is reprinted from Clinical Cancer Research, 2018, 24/11, 2482-2490, Ashton TM, McKenna WG, Kunz-Schughart LA, Higgins GS, Oxidative Phosphorylation as an Emerging Target in Cancer Therapy, with permission from AACR. The right portion of the figure is adapted from Cancer Research, 2016, 76/13, 3904-3915, Cheng G, Zielonka J, Ouari O, Lopez M, McAllister D, Boyle K, Barrios CS, Weber JJ, Johnson BD, Hardy M, Dwinell MB, Kalyanaraman B, Mitochondria-Targeted Analogues of Metformin Exhibit Enhanced Antiproliferative and Radiosensitizing Effects in Pancreatic Cancer Cells, with permission from AACR.